Studies in animal models have shown that the effect of obestatin on food intake is opposite to ghrelin, and obestatin has been suggested to provide a new target for the control of obesity [15,16]. This evidence concerns the gene GHRL and obesity due to melanocortin 4 receptor deficiency.